Could mangosteen help control type 2 diabetes?
NCT ID NCT07172269
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether adding a mangosteen supplement to standard diabetes drugs (sitagliptin/metformin) improves blood sugar control in 47 adults with type 2 diabetes. Participants took either the standard drugs alone or with mangosteen for 12 weeks. Researchers measured changes in HbA1c, insulin resistance, and inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mangosteen supplement (Garcinia mangostana extract)
- What this could lead to
- If it works, this could point toward a natural supplement to help manage blood sugar and reduce inflammation in type 2 diabetes.
- What could go wrong
- This is a small, early-stage trial with only 47 patients. Results may not apply to everyone, and supplements are not a replacement for standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Diabetes Center for Treatment and Research
Baghdad, Iraq
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?